Published Online First: 18 May 2007. doi:10.1136/jcp.2006.043679
Journal of Clinical Pathology 2008;61:25-30
Copyright © 2008 by the BMJ Publishing Group Ltd & Association of Clinical Pathologists.
Molecular pathology of familial gastric cancer, with an emphasis on hereditary diffuse gastric cancer
F Carneiro1,2,3,
C Oliveira1,2,
G Suriano1,2,
R Seruca1,2
1 Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP), Porto, Portugal
2 Medical Faculty of the University of Porto, Porto, Portugal
3 Department of Pathology, Hospital S. João, Porto, Portugal
Correspondence to:
Dr Fátima Carneiro, Rua Dr Roberto frias s/n, 4200-465 Porto, Portugal; fcarneiro{at}ipatimup.pt
Gastric cancer is one of the major causes of cancer-related death worldwide. Familial clustering is observed in about 10% of cases; 1–3% of cases are hereditary. In the latter group, a syndrome which has been well characterised is hereditary diffuse gastric cancer; this is specifically associated with CDH1 (E-cadherin) germline mutations in about 30% of families. In this article, the state of the art of familial gastric cancer regarding the clinical, molecular and pathology features is reviewed, as well as the practical aspects for a correct diagnosis and clinical management.
Terms and conditions relating to subscriptions purchased online ¦ Website terms and conditions ¦ Privacy policy
Copyright © 2008 by the BMJ Publishing Group Ltd & Association of Clinical Pathologists.